Cargando…

Association of Thrombus Aspiration With Time and Mortality Among Patients With ST-Segment Elevation Myocardial Infarction: A Post Hoc Analysis of the Randomized TOTAL Trial

IMPORTANCE: Patients with shorter ischemic times have a greater viable myocardium and may derive greater benefit from thrombus aspiration. OBJECTIVE: To study the association of thrombus aspiration with outcomes among patients presenting with ST-segment elevation myocardial infarction (STEMI) based...

Descripción completa

Detalles Bibliográficos
Autores principales: Moxham, Rachel, Džavík, Vladimír, Cairns, John, Natarajan, Madhu K., Bainey, Kevin R., Akl, Elie, Tsang, Michael B., Lavi, Shahar, Cantor, Warren J., Madan, Mina, Liu, Yan Yun, Jolly, Sanjit S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998077/
https://www.ncbi.nlm.nih.gov/pubmed/33769510
http://dx.doi.org/10.1001/jamanetworkopen.2021.3505
_version_ 1783670468481384448
author Moxham, Rachel
Džavík, Vladimír
Cairns, John
Natarajan, Madhu K.
Bainey, Kevin R.
Akl, Elie
Tsang, Michael B.
Lavi, Shahar
Cantor, Warren J.
Madan, Mina
Liu, Yan Yun
Jolly, Sanjit S.
author_facet Moxham, Rachel
Džavík, Vladimír
Cairns, John
Natarajan, Madhu K.
Bainey, Kevin R.
Akl, Elie
Tsang, Michael B.
Lavi, Shahar
Cantor, Warren J.
Madan, Mina
Liu, Yan Yun
Jolly, Sanjit S.
author_sort Moxham, Rachel
collection PubMed
description IMPORTANCE: Patients with shorter ischemic times have a greater viable myocardium and may derive greater benefit from thrombus aspiration. OBJECTIVE: To study the association of thrombus aspiration with outcomes among patients presenting with ST-segment elevation myocardial infarction (STEMI) based on time. DESIGN, SETTING, AND PARTICIPANTS: The TOTAL (Thrombectomy With PCI vs PCI Alone in Patients with STEMI) trial was an international randomized clinical trial of 10 732 patients with STEMI undergoing primary percutaneous coronary intervention (PCI) within 12 hours of symptom onset. Patients were recruited between August 5, 2010, and July 25, 2014, and were followed up for 1 year. Data analysis was performed from February 22, 2019, to January 5, 2021. INTERVENTIONS: Thrombus aspiration vs PCI alone. MAIN OUTCOMES AND MEASURES: Post hoc subgroup analyses were performed for total ischemic time and first medical contact (FMC)–to–device time for the primary outcomes (cardiovascular [CV] mortality, myocardial Infarction [MI], cardiogenic shock, and New York Heart Association class IV heart failure) and angiographically determined distal embolization. In addition, a multivariable analysis was performed to assess the association of total ischemic time and FMC-to-device time with CV mortality at 1 year. RESULTS: The study randomized 10 732 patients, and 9986 underwent primary PCI and had time data available (7737 men [77.5%]; mean [SD] age, 61.0 [12.0] years). For the randomized comparison of thrombus aspiration, there was a reduction in angiographic distal embolization with thrombus aspiration that was more pronounced in patients with short ischemic times (<2 hours: odds ratio [OR], 0.23 [95% CI, 0.09-0.62]; 2-6 hours: OR, 0.54 [95% CI, 0.39-0.73]; >6 hours: OR, 0.70 [95% CI, 0.33-1.50]; P = .12 for interaction). However, for the primary composite outcome, there was no benefit based on (1) total ischemic time (<2 hours: hazard ratio [HR], 0.77 [95% CI, 0.46-1.28]; 2-6 hours: HR, 1.03 [95% CI, 0.85-1.25]; >6 hours: HR, 0.87 [95% CI, 0.60-1.27]; P = .46 for interaction) or (2) FMC-to-device time (<60 minutes: HR, 1.14 [95% CI, 0.66-1.95]; 60-90 minutes: HR, 0.94 [95% CI, 0.67-1.32]; >90-120 minutes: HR, 1.19 [95% CI, 0.85-1.67]; >120 minutes: HR, 0.89 [95% CI, 0.70-1.14]; P = .54 for interaction). In a multivariable analysis, both total ischemic time (>2 hours: HR, 1.26 [95% CI, 1.00-1.58) and FMC-to-device time (>120 minutes: HR, 1.45 [95% CI, 1.18-1.79]) were independently associated with CV mortality. CONCLUSIONS AND RELEVANCE: This analysis suggests that thrombus aspiration does not appear to be associated with an improvement in clinical outcomes regardless of ischemic time. In the current STEMI era, both total ischemic time and FMC-to-device times continue to be important factors associated with mortality. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01149044
format Online
Article
Text
id pubmed-7998077
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-79980772021-04-19 Association of Thrombus Aspiration With Time and Mortality Among Patients With ST-Segment Elevation Myocardial Infarction: A Post Hoc Analysis of the Randomized TOTAL Trial Moxham, Rachel Džavík, Vladimír Cairns, John Natarajan, Madhu K. Bainey, Kevin R. Akl, Elie Tsang, Michael B. Lavi, Shahar Cantor, Warren J. Madan, Mina Liu, Yan Yun Jolly, Sanjit S. JAMA Netw Open Original Investigation IMPORTANCE: Patients with shorter ischemic times have a greater viable myocardium and may derive greater benefit from thrombus aspiration. OBJECTIVE: To study the association of thrombus aspiration with outcomes among patients presenting with ST-segment elevation myocardial infarction (STEMI) based on time. DESIGN, SETTING, AND PARTICIPANTS: The TOTAL (Thrombectomy With PCI vs PCI Alone in Patients with STEMI) trial was an international randomized clinical trial of 10 732 patients with STEMI undergoing primary percutaneous coronary intervention (PCI) within 12 hours of symptom onset. Patients were recruited between August 5, 2010, and July 25, 2014, and were followed up for 1 year. Data analysis was performed from February 22, 2019, to January 5, 2021. INTERVENTIONS: Thrombus aspiration vs PCI alone. MAIN OUTCOMES AND MEASURES: Post hoc subgroup analyses were performed for total ischemic time and first medical contact (FMC)–to–device time for the primary outcomes (cardiovascular [CV] mortality, myocardial Infarction [MI], cardiogenic shock, and New York Heart Association class IV heart failure) and angiographically determined distal embolization. In addition, a multivariable analysis was performed to assess the association of total ischemic time and FMC-to-device time with CV mortality at 1 year. RESULTS: The study randomized 10 732 patients, and 9986 underwent primary PCI and had time data available (7737 men [77.5%]; mean [SD] age, 61.0 [12.0] years). For the randomized comparison of thrombus aspiration, there was a reduction in angiographic distal embolization with thrombus aspiration that was more pronounced in patients with short ischemic times (<2 hours: odds ratio [OR], 0.23 [95% CI, 0.09-0.62]; 2-6 hours: OR, 0.54 [95% CI, 0.39-0.73]; >6 hours: OR, 0.70 [95% CI, 0.33-1.50]; P = .12 for interaction). However, for the primary composite outcome, there was no benefit based on (1) total ischemic time (<2 hours: hazard ratio [HR], 0.77 [95% CI, 0.46-1.28]; 2-6 hours: HR, 1.03 [95% CI, 0.85-1.25]; >6 hours: HR, 0.87 [95% CI, 0.60-1.27]; P = .46 for interaction) or (2) FMC-to-device time (<60 minutes: HR, 1.14 [95% CI, 0.66-1.95]; 60-90 minutes: HR, 0.94 [95% CI, 0.67-1.32]; >90-120 minutes: HR, 1.19 [95% CI, 0.85-1.67]; >120 minutes: HR, 0.89 [95% CI, 0.70-1.14]; P = .54 for interaction). In a multivariable analysis, both total ischemic time (>2 hours: HR, 1.26 [95% CI, 1.00-1.58) and FMC-to-device time (>120 minutes: HR, 1.45 [95% CI, 1.18-1.79]) were independently associated with CV mortality. CONCLUSIONS AND RELEVANCE: This analysis suggests that thrombus aspiration does not appear to be associated with an improvement in clinical outcomes regardless of ischemic time. In the current STEMI era, both total ischemic time and FMC-to-device times continue to be important factors associated with mortality. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01149044 American Medical Association 2021-03-26 /pmc/articles/PMC7998077/ /pubmed/33769510 http://dx.doi.org/10.1001/jamanetworkopen.2021.3505 Text en Copyright 2021 Moxham R et al. JAMA Network Open. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Moxham, Rachel
Džavík, Vladimír
Cairns, John
Natarajan, Madhu K.
Bainey, Kevin R.
Akl, Elie
Tsang, Michael B.
Lavi, Shahar
Cantor, Warren J.
Madan, Mina
Liu, Yan Yun
Jolly, Sanjit S.
Association of Thrombus Aspiration With Time and Mortality Among Patients With ST-Segment Elevation Myocardial Infarction: A Post Hoc Analysis of the Randomized TOTAL Trial
title Association of Thrombus Aspiration With Time and Mortality Among Patients With ST-Segment Elevation Myocardial Infarction: A Post Hoc Analysis of the Randomized TOTAL Trial
title_full Association of Thrombus Aspiration With Time and Mortality Among Patients With ST-Segment Elevation Myocardial Infarction: A Post Hoc Analysis of the Randomized TOTAL Trial
title_fullStr Association of Thrombus Aspiration With Time and Mortality Among Patients With ST-Segment Elevation Myocardial Infarction: A Post Hoc Analysis of the Randomized TOTAL Trial
title_full_unstemmed Association of Thrombus Aspiration With Time and Mortality Among Patients With ST-Segment Elevation Myocardial Infarction: A Post Hoc Analysis of the Randomized TOTAL Trial
title_short Association of Thrombus Aspiration With Time and Mortality Among Patients With ST-Segment Elevation Myocardial Infarction: A Post Hoc Analysis of the Randomized TOTAL Trial
title_sort association of thrombus aspiration with time and mortality among patients with st-segment elevation myocardial infarction: a post hoc analysis of the randomized total trial
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998077/
https://www.ncbi.nlm.nih.gov/pubmed/33769510
http://dx.doi.org/10.1001/jamanetworkopen.2021.3505
work_keys_str_mv AT moxhamrachel associationofthrombusaspirationwithtimeandmortalityamongpatientswithstsegmentelevationmyocardialinfarctionaposthocanalysisoftherandomizedtotaltrial
AT dzavikvladimir associationofthrombusaspirationwithtimeandmortalityamongpatientswithstsegmentelevationmyocardialinfarctionaposthocanalysisoftherandomizedtotaltrial
AT cairnsjohn associationofthrombusaspirationwithtimeandmortalityamongpatientswithstsegmentelevationmyocardialinfarctionaposthocanalysisoftherandomizedtotaltrial
AT natarajanmadhuk associationofthrombusaspirationwithtimeandmortalityamongpatientswithstsegmentelevationmyocardialinfarctionaposthocanalysisoftherandomizedtotaltrial
AT baineykevinr associationofthrombusaspirationwithtimeandmortalityamongpatientswithstsegmentelevationmyocardialinfarctionaposthocanalysisoftherandomizedtotaltrial
AT aklelie associationofthrombusaspirationwithtimeandmortalityamongpatientswithstsegmentelevationmyocardialinfarctionaposthocanalysisoftherandomizedtotaltrial
AT tsangmichaelb associationofthrombusaspirationwithtimeandmortalityamongpatientswithstsegmentelevationmyocardialinfarctionaposthocanalysisoftherandomizedtotaltrial
AT lavishahar associationofthrombusaspirationwithtimeandmortalityamongpatientswithstsegmentelevationmyocardialinfarctionaposthocanalysisoftherandomizedtotaltrial
AT cantorwarrenj associationofthrombusaspirationwithtimeandmortalityamongpatientswithstsegmentelevationmyocardialinfarctionaposthocanalysisoftherandomizedtotaltrial
AT madanmina associationofthrombusaspirationwithtimeandmortalityamongpatientswithstsegmentelevationmyocardialinfarctionaposthocanalysisoftherandomizedtotaltrial
AT liuyanyun associationofthrombusaspirationwithtimeandmortalityamongpatientswithstsegmentelevationmyocardialinfarctionaposthocanalysisoftherandomizedtotaltrial
AT jollysanjits associationofthrombusaspirationwithtimeandmortalityamongpatientswithstsegmentelevationmyocardialinfarctionaposthocanalysisoftherandomizedtotaltrial